-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Selegiline, also known as l-deprenyl, is a medication that is used to treat Parkinson's disease.
It is a selective monoamine oxidase-B (MAO-B) inhibitor, which means that it blocks the action of an enzyme that breaks down certain chemicals in the brain.
This can help to increase the levels of certain chemicals, such as dopamine, which are depleted in Parkinson's disease.
Selegiline is generally considered to be a safe medication when used as directed.
However, it is important to note that it can have serious side effects, particularly at higher doses.
It is also important to use selegiline carefully and under the guidance of a healthcare professional, as it can interact with other medications and may not be suitable for certain people.
One of the main safety concerns with selegiline is the risk of serotonin syndrome, which is a potentially life-threatening condition that occurs when the levels of serotonin in the body become too high.
Serotonin is a chemical that is involved in mood regulation and other functions in the body.
Selegiline can increase the levels of serotonin in the body, which can lead to serotonin syndrome if it is taken in combination with other medications that also increase serotonin levels.
Symptoms of serotonin syndrome can include confusion, agitation, hallucinations, muscle rigidity, and changes in blood pressure.
If you experience any of these symptoms while taking selegiline, it is important to seek medical attention immediately.
Another potential safety concern with selegiline is the risk of a condition called tardive dyskinesia.
This is a movement disorder that can occur as a result of long-term use of certain medications, including selegiline.
It is characterized by involuntary movements of the face, tongue, or limbs.
While the risk of tardive dyskinesia is generally low with selegiline, it can increase with longer-term use.
It is important to note that selegiline should not be used in certain people, such as those with a history of heart disease, lung disease, or liver disease.
It should also not be used in pregnant or breastfeeding women, or in people with a history of drug abuse.
In conclusion, selegiline is a medication that is used to treat Parkinson's disease, and is generally considered to be safe when used as directed.
However, it can have serious side effects, particularly at higher doses, and should be used carefully and under the guidance of a healthcare professional.
It is important to be aware of the potential risks of serotonin syndrome and tardive dyskinesia, and to seek medical attention if any symptoms occur.